Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias.
Seasonal influenza epidemics and occasional pandemics threaten public health worldwide. New alternative strategies for generating recombinant viruses with vaccine potential are needed. Interestingly, influenza viruses circulating in different hosts have been found to have distinct codon usage patterns, which may reflect host adaptation. We therefore hypothesized that it is possible to make a human seasonal influenza virus that is specifically attenuated in human cells but not in eggs by converting its codon usage so that it is similar to that observed from avian influenza viruses. This approach might help to generate human live attenuated viruses without affecting their yield in eggs. To test this hypothesis, over 300 silent mutations were introduced into the genome of a seasonal H1N1 influenza virus. The resultant mutant was significantly attenuated in mammalian cells and mice, yet it grew well in embryonated eggs. A single dose of intranasal vaccination induced potent innate, humoral, and cellular immune responses, and the mutant could protect mice against homologous and heterologous viral challenges. The attenuated mutant could also be used as a vaccine master donor strain by introducing hemagglutinin and neuraminidase genes derived from other strains. Thus, our approach is a successful strategy to generate attenuated viruses for future application as vaccines.


OBJECTIVE
Vaccination has been one of the best protective measures in combating influenza virus infection. Current licensed influenza vaccines and their production have various limitations. Our virus attenuation strategy makes use of the codon usage biases of human and avian influenza viruses to generate a human-derived influenza virus that is attenuated in mammalian hosts. This method, however, does not affect virus replication in eggs. This makes the resultant mutants highly compatible with existing egg-based vaccine production pipelines. The viral proteins generated from the codon bias mutants are identical to the wild-type viral proteins. In addition, our massive genome-wide mutational approach further minimizes the concern over reverse mutations. The potential use of this kind of codon bias mutant as a master donor strain to generate other live attenuated viruses is also demonstrated. These findings put forward a promising live attenuated influenza vaccine generation strategy to control influenza.
Centre of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
Rebecca L Y
RL
Fan
Centre of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
Sophie A
SA
Valkenburg
Centre of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
Chloe K S
CK
Wong
Centre of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
Olive T W
OT
Li
Department of Pathology, The University of Hong Kong, Hong Kong, SAR, China.
John M
JM
Nicholls
Department of Systems Biology and Department of Biomedical Informatics, Columbia University College of Physicians and Surgeons, New York, New York, USA.
Raul
R
Rabadan
Centre of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong, SAR, China.
J S Malik
JS
Peiris
Centre of Influenza Research and School of Public Health, The University of Hong Kong, Hong Kong, SAR, China llmpoon@hku.hk.
Leo L M
LL
Poon
D000818:Animals; D003062:Codon / Q000235:genetics*; D004285:Dogs; D004531:Eggs / Q000821:virology; D005818:Genetic Engineering / Q000379:methods*; D057809:HEK293 Cells; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics*; D007252:Influenza Vaccines / Q000096:biosynthesis* / Q000235:genetics* / Q000276:immunology*; D061985:Madin Darby Canine Kidney Cells; D051379:Mice; D016296:Mutagenesis
D003062:Codon; D007252:Influenza Vaccines